Skip to main content
. 2017 Mar 13;87(Suppl 363):39–46. doi: 10.1080/17453674.2017.1297916

Clinical trials of cellular therapies for intervertebral disc repair

Title Place ClinicalTrials.gov identifier Status
Autologous adipose derived stem cell therapy for intervertebral disc degeneration Bundang CHA Hospital, Korea NCT02338271 Recruiting
Treatment of degenerative disc disease with allogeneic mesenchymal stem cells Hospital Clinico Universitario, Valladolid, Spain NCT01860417 Ongoing, not recruiting
Autologous adipose tissue derived mesenchymal stem cell transplantation in patient with lumbar intervertebral disc degeneration Biostar, Korea University Anam Hospital NCT01643681 Unknown
Safety and preliminary efficacy study of mesenchymal precursor cells (MPCs) in subjects with lumbar back pain Mesoblast Ltd. NCT01290367 Completed but no results posted
Safety and efficacy study of rexlemestrocel-L (viz. allogenic MSCs) in subjects with chronic discogenic lumbar back pain Mesoblast Ltd. NCT02412735 Recruiting
Lumbar degenerative disc disease treatment with bone marrow autologous mesenchymal stem cells (MSV) Red de Terapia Celular, Spain NCT02440074 Withdrawn
Human autograft mesenchymal stem cell mediated stabilization of the degnerative lumbar spine Trinity Stem Cell Institution, Odessa, Florida, USA NCT02529566 Enrolling by invitation
Adipose cells for degenerative disc disease Bioheart Inc. NCT02097862 Recruiting
Safety and efficacy with NOVOCART disc plus (ADCT) for the treatment of degenerative disc disease in lumbar spine (NDisc) Tetec AG NCT01640457 Ongoing, not recruiting
A study comparing the safety and effectiveness of cartilage cells injected into the lumbar disc as compared to a placebo ISTO Technologies Inc., USA NCT01771471 Ongoing, not recruiting